RxDoctor Payments Data

Bradley Jenkins

Nurse Practitioner · Roosevelt, UTNPI 1912968538

Payments from drug & device makers

$1,567in general payments, 2019–2025

Across 95 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$464
  • Lilly USA, LLC$201
  • Axsome Therapeutics, Inc.$129
  • Novo Nordisk$108
  • Dexcom, Inc.$89
  • Corcept Therapeutics$72
  • plus $506 from 15 others

What the payments were for

  • Food & beverage$1,567100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,567 in reported general payments places this provider in the 80th percentile of 979 nurse practitioner providers in Utah.

See all nurse practitioner providers in Utah

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide61$74,314
XareltoRivaroxaban45$61,465
JardianceEmpagliflozin43$53,364
Trelegy ElliptaFluticasone/Umeclidin/Vilanter70$49,846
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog67$49,184
TrulicityDulaglutide41$42,906
EliquisApixaban25$36,256
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog24$18,323
Stiolto RespimatTiotropium Br/Olodaterol Hcl20$9,501
Tresiba Flextouch U-200Insulin Degludec15$9,500
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$7,521
FarxigaDapagliflozin Propanediol11$6,407
Humalog Kwikpen U-100Insulin Lispro15$5,183
Omeprazole273$4,711
Ventolin HfaAlbuterol Sulfate38$4,535

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$108$74,31461 claims
Boehringer IngelheimJardiance, Stiolto Respimat$37$62,86563 claims
Johnson & JohnsonXarelto$15$61,46545 claims
GSKTrelegy Ellipta$15$49,84670 claims
Lilly USA, LLCTrulicity$201$42,90641 claims
AstraZenecaFarxiga$66$6,40711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 979 nurse practitioner providers in Utah.

Other nurse practitioner in Roosevelt

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →